Literature DB >> 20582479

In reply to: Association between utility and treatment among patients with prostate cancer.

Pranav Gandhi1, Joshua Spooner, I-Chan Huang.   

Abstract

This is a brief commentary in response to article-Jayadevappa et al. (Qual Life Res 19:711-729, 2010). The commentary draws attention to issues that complicate QoL assessments in generic and disease-specific measures and its association to the treatment.

Entities:  

Mesh：

Year:  2010        PMID： 20582479     DOI： 10.1007/s11136-010-9698-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN： 0962-9343            Impact factor:   4.147


  7 in total

1.  Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research.

Authors:  C E Schwartz; M A Sprangers
Journal:  Soc Sci Med       Date:  1999-06       Impact factor: 4.634

Review 2.  Assessing meaningful change in quality of life over time: a users' guide for clinicians.

Authors:  Mirjam A G Sprangers; Carol M Moinpour; Timothy J Moynihan; Donald L Patrick; Dennis A Revicki
Journal:  Mayo Clin Proc       Date:  2002-06       Impact factor: 7.616

3.  Prostate cancer diagnosis: the impact on patients' mental health.

Authors:  Ida J Korfage; Harry J de Koning; Monique Roobol; Fritz H Schröder; Marie-Louise Essink-Bot
Journal:  Eur J Cancer       Date:  2005-12-02       Impact factor: 9.162

4.  Patients' perceptions of the side-effects of prostate cancer treatment--a qualitative interview study.

Authors:  Ida Joanna Korfage; Tony Hak; Harry J de Koning; Marie-Louise Essink-Bot
Journal:  Soc Sci Med       Date:  2006-08       Impact factor: 4.634

5.  Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.

Authors:  J B Madalinska; M L Essink-Bot; H J de Koning; W J Kirkels; P J van der Maas; F H Schröder
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

6.  Association between utility and treatment among patients with prostate cancer.

Authors:  Ravishankar Jayadevappa; J Sanford Schwartz; Sumedha Chhatre; Alan J Wein; S Bruce Malkowicz
Journal:  Qual Life Res       Date:  2010-03-05       Impact factor: 4.147

7.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.